Fennec Pharma Competitors and Similar CompaniesClear all
Fennec Pharma's competitors and similar companies include Urogen Pharma.
 Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | ||
Founding Date | Founding Date 1996 | Founding Date 2004 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US |
Employees | Employees 433% increase | Employees 194362% increase |
Valuation ($) | Valuation ($) 129.4 m | Valuation ($) 515.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) |
Net income | Net income ($9.7m) (FY, 2025) | Net income ($153.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View company